Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANI PHARMACEUTICALS INC Director's Dealing 2016

Apr 12, 2016

31676_dirs_2016-04-11_edd174ef-e6b1-47e7-97a0-d308e705dab9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2016-04-07

Reporting Person: Penn Thomas A. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-04-07 Common Stock A 1000 $0.00 Acquired 10110 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-04-07 Option to Purchase $40.59 A 2000 Acquired 2026-04-06 Common Stock (2000) Direct

Footnotes

F1: On April 7, 2016, the Board of Directors of the Issuer approved the grant of restricted stock and stock options reported herein, both of which vest on the first anniversary of the grant date.

F2: The closing price of the Issuer's common stock on The NASDAQ Global Market on the grant date.